Cervical disc arthroplasty: 10-year outcomes of the Prestige LP cervical disc at a single level

MF Gornet, JK Burkus, ME Shaffrey… - … of Neurosurgery: Spine, 2019 - thejns.org
OBJECTIVE Food and Drug Administration–approved investigational device exemption
(IDE) studies have provided level I evidence supporting cervical disc arthroplasty (CDA) as a …

Cervical disc arthroplasty with PRESTIGE LP disc versus anterior cervical discectomy and fusion: a prospective, multicenter investigational device exemption study

MF Gornet, JK Burkus, ME Shaffrey, PJ Argires… - … of Neurosurgery: Spine, 2015 - thejns.org
OBJECT This study compared the safety and efficacy of treatment with the PRESTIGE LP
cervical disc versus a historical control anterior cervical discectomy and fusion (ACDF) …

Cervical disc arthroplasty with the Prestige LP disc versus anterior cervical discectomy and fusion, at 2 levels: results of a prospective, multicenter randomized …

MF Gornet, TH Lanman, JK Burkus, SD Hodges… - … of Neurosurgery: Spine, 2017 - thejns.org
OBJECTIVE The authors compared the efficacy and safety of arthroplasty using the Prestige
LP cervical disc with those of anterior cervical discectomy and fusion (ACDF) for the …

Cervical disc arthroplasty with Prestige LP disc versus anterior cervical discectomy and fusion: seven-year outcomes

MF Gornet, JK Burkus, ME Shaffrey, H Nian… - International journal of …, 2016 - ijssurgery.com
Background Cervical disc arthroplasty (CDA) has emerged as an alternative to anterior
cervical discectomy and fusion (ACDF) for the treatment of cervical pathologies. Studies are …

Two-level cervical disc arthroplasty versus anterior cervical discectomy and fusion: 10-year outcomes of a prospective, randomized investigational device exemption …

MF Gornet, TH Lanman, JK Burkus, RF Dryer… - … of Neurosurgery: Spine, 2019 - thejns.org
OBJECTIVE The authors assessed the 10-year clinical safety and effectiveness of cervical
disc arthroplasty (CDA) to treat degenerative cervical spine disease at 2 adjacent levels …

Prospective study of cervical arthroplasty in 98 patients involved in 1 of 3 separate investigational device exemption studies from a single investigational site with a …

D Coric, J Cassis, JD Carew, MO Boltes - Journal of Neurosurgery: Spine, 2010 - thejns.org
Object Cervical total disc replacement (TDR) was developed to address some of the
shortcomings associated with anterior cervical discectomy and fusion (ACDF) by preserving …

Long-term clinical and radiographic outcomes of cervical disc replacement with the Prestige disc: results from a prospective randomized controlled clinical trial …

JK Burkus, RW Haid, VC Traynelis… - Journal of Neurosurgery …, 2010 - thejns.org
Object The purpose of this study was to determine long-term clinical outcomes in patients
undergoing anterior cervical surgery in which a cervical disc prosthesis was used to treat …

Long-term evaluation of cervical disc arthroplasty with the Mobi-C© cervical disc: a randomized, prospective, multicenter clinical trial with seven-year follow-up

K Radcliff, RJ Davis, MS Hisey, PD Nunley… - International journal of …, 2017 - ijssurgery.com
Background Cervical total disc replacement (TDR) is an increasingly accepted procedure for
the treatment of symptomatic cervical degenerative disc disease. Multiple Level I evidence …

Long-term clinical outcomes of cervical disc arthroplasty: a prospective, randomized, controlled trial

WR Sasso, JD Smucker, MP Sasso, RC Sasso - 2017 - journals.lww.com
Study Design. Prospective, randomized, single-center, clinical trial. Objective. To
prospectively examine the 7-and 10-year outcomes of cervical arthroplasty to anterior …

Clinical and radiographic analysis of an artificial cervical disc: 7-year follow-up from the Prestige prospective randomized controlled clinical trial

JK Burkus, VC Traynelis, RW Haid… - Journal of Neurosurgery …, 2014 - thejns.org
Object The authors assess the long-term safety and efficacy of cervical disc replacement
with the Prestige Cervical Disc in a prospective, randomized, multicenter trial at 7 years of …